Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 6 | 2025 | 1867 | 1.520 |
Why?
|
| Child Development | 3 | 2022 | 288 | 0.790 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2024 | 1165 | 0.680 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 656 | 0.610 |
Why?
|
| NADPH Oxidases | 4 | 2009 | 111 | 0.610 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 551 | 0.610 |
Why?
|
| Health Information Systems | 1 | 2019 | 32 | 0.600 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 667 | 0.580 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 430 | 0.550 |
Why?
|
| Developmental Disabilities | 2 | 2019 | 748 | 0.530 |
Why?
|
| Hippocampus | 6 | 2009 | 819 | 0.530 |
Why?
|
| Referral and Consultation | 1 | 2019 | 569 | 0.460 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 2 | 2009 | 42 | 0.380 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2009 | 372 | 0.330 |
Why?
|
| Organ Culture Techniques | 2 | 2009 | 157 | 0.320 |
Why?
|
| Synapses | 4 | 2008 | 461 | 0.320 |
Why?
|
| Risk Assessment | 1 | 2019 | 3710 | 0.310 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 142 | 0.300 |
Why?
|
| Heart Arrest, Induced | 1 | 2009 | 77 | 0.300 |
Why?
|
| Hyperglycemia | 1 | 2010 | 238 | 0.290 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2009 | 82 | 0.290 |
Why?
|
| Manganese | 1 | 2008 | 58 | 0.280 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 234 | 0.280 |
Why?
|
| Axons | 1 | 2010 | 394 | 0.270 |
Why?
|
| Oxidative Stress | 2 | 2010 | 800 | 0.250 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 514 | 0.250 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 475 | 0.240 |
Why?
|
| Neuronal Plasticity | 2 | 2006 | 277 | 0.240 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 5405 | 0.230 |
Why?
|
| Brain | 2 | 2009 | 3197 | 0.220 |
Why?
|
| North America | 1 | 2025 | 265 | 0.220 |
Why?
|
| Superoxides | 2 | 2005 | 133 | 0.220 |
Why?
|
| Infant | 5 | 2024 | 13192 | 0.220 |
Why?
|
| Energy Metabolism | 1 | 2009 | 804 | 0.210 |
Why?
|
| Nervous System Diseases | 1 | 2008 | 410 | 0.210 |
Why?
|
| Risk Factors | 4 | 2023 | 10910 | 0.210 |
Why?
|
| Language Development Disorders | 1 | 2024 | 179 | 0.200 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2002 | 1 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2010 | 3853 | 0.200 |
Why?
|
| Connective Tissue Diseases | 1 | 2023 | 32 | 0.200 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 173 | 0.190 |
Why?
|
| Retrospective Studies | 5 | 2024 | 17363 | 0.180 |
Why?
|
| Male | 14 | 2025 | 65052 | 0.180 |
Why?
|
| Child | 5 | 2025 | 25823 | 0.170 |
Why?
|
| Aging | 2 | 2006 | 1261 | 0.170 |
Why?
|
| Microdialysis | 2 | 2009 | 57 | 0.150 |
Why?
|
| Child, Preschool | 4 | 2025 | 14851 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2002 | 927 | 0.150 |
Why?
|
| Nervous System | 1 | 2019 | 127 | 0.150 |
Why?
|
| Lactic Acid | 2 | 2009 | 159 | 0.150 |
Why?
|
| Oxygen Consumption | 2 | 2009 | 308 | 0.140 |
Why?
|
| Animals | 13 | 2010 | 34989 | 0.140 |
Why?
|
| Seizures | 1 | 2023 | 895 | 0.140 |
Why?
|
| Child Behavior | 1 | 2019 | 235 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2024 | 802 | 0.130 |
Why?
|
| Postoperative Care | 1 | 2019 | 311 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 269 | 0.130 |
Why?
|
| Female | 7 | 2025 | 70786 | 0.120 |
Why?
|
| Humans | 10 | 2025 | 132334 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 3980 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 1227 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8566 | 0.100 |
Why?
|
| Incidence | 1 | 2019 | 3361 | 0.090 |
Why?
|
| Mice | 8 | 2010 | 18571 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2008 | 4767 | 0.090 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2010 | 24 | 0.080 |
Why?
|
| Texas | 1 | 2019 | 3628 | 0.080 |
Why?
|
| Rats | 2 | 2009 | 3619 | 0.080 |
Why?
|
| Onium Compounds | 1 | 2009 | 4 | 0.080 |
Why?
|
| Aconitine | 1 | 2009 | 8 | 0.080 |
Why?
|
| Acetophenones | 1 | 2009 | 13 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 637 | 0.080 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2009 | 56 | 0.080 |
Why?
|
| Intraoperative Period | 1 | 2009 | 71 | 0.080 |
Why?
|
| Glycerol | 1 | 2009 | 96 | 0.080 |
Why?
|
| Sus scrofa | 1 | 2009 | 123 | 0.070 |
Why?
|
| Nicotine | 1 | 2009 | 119 | 0.070 |
Why?
|
| Receptors, Nicotinic | 1 | 2009 | 133 | 0.070 |
Why?
|
| Body Temperature | 1 | 2009 | 128 | 0.070 |
Why?
|
| Probability | 1 | 2009 | 323 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2009 | 132 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 396 | 0.070 |
Why?
|
| Memantine | 1 | 2008 | 18 | 0.070 |
Why?
|
| Random Allocation | 1 | 2009 | 431 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 440 | 0.070 |
Why?
|
| Isoflurane | 1 | 2008 | 38 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2009 | 618 | 0.070 |
Why?
|
| Perfusion | 1 | 2009 | 209 | 0.070 |
Why?
|
| Gene Expression | 2 | 2010 | 1564 | 0.070 |
Why?
|
| Brain Mapping | 1 | 2010 | 406 | 0.070 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 28 | 0.060 |
Why?
|
| Base Sequence | 1 | 2010 | 2904 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2005 | 1723 | 0.060 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2006 | 26 | 0.060 |
Why?
|
| Contrast Media | 1 | 2010 | 508 | 0.060 |
Why?
|
| Swine | 1 | 2009 | 1197 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1035 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 1443 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 1297 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 176 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 246 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 149 | 0.060 |
Why?
|
| Time Factors | 2 | 2019 | 6455 | 0.060 |
Why?
|
| Protein Transport | 1 | 2006 | 370 | 0.060 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2005 | 43 | 0.060 |
Why?
|
| Long-Term Potentiation | 1 | 2005 | 110 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 2145 | 0.050 |
Why?
|
| Survival Rate | 1 | 2009 | 2187 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2006 | 474 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 118 | 0.050 |
Why?
|
| Hypoxia | 1 | 2005 | 261 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2003 | 96 | 0.050 |
Why?
|
| Pseudorabies | 1 | 2002 | 1 | 0.050 |
Why?
|
| Amygdala | 1 | 2003 | 85 | 0.050 |
Why?
|
| Thalamus | 1 | 2003 | 88 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 28 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 92 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 222 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2023 | 198 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 4695 | 0.040 |
Why?
|
| Recurrence | 1 | 2024 | 1458 | 0.040 |
Why?
|
| Monocytes | 1 | 2002 | 345 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 482 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2008 | 3873 | 0.040 |
Why?
|
| Software | 1 | 2024 | 727 | 0.040 |
Why?
|
| Language Development | 1 | 2019 | 36 | 0.040 |
Why?
|
| Virus Replication | 1 | 2002 | 636 | 0.040 |
Why?
|
| Macrophages | 1 | 2002 | 693 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 1017 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2009 | 3139 | 0.030 |
Why?
|
| Motor Activity | 1 | 2019 | 521 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 814 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3742 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 6540 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 2931 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2010 | 174 | 0.020 |
Why?
|
| United States | 1 | 2023 | 11627 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 615 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2006 | 118 | 0.010 |
Why?
|
| NADPH Oxidase 2 | 1 | 2005 | 38 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2005 | 42 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2006 | 383 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 2005 | 21 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 90 | 0.010 |
Why?
|
| Cytosol | 1 | 2005 | 144 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 358 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 13016 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 421 | 0.010 |
Why?
|
| Learning | 1 | 2006 | 370 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 2453 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 3062 | 0.010 |
Why?
|